NCT07127861 Effects of Treadmill-Based Gait Training in Patients With Stroke
| NCT ID | NCT07127861 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Salamanca |
| Condition | Gait |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-09-14 |
| Primary Completion | 2025-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-09-14 with a primary completion date of 2025-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hemiplegia is one of the most common sequelae after stroke. Most patients develop thermal asymmetry between the affected and contralateral sides of the body, as well as an asymmetric gait pattern characterized by differences in the duration of gait cycle phases, step length, cadence, and weight distribution between limbs. These patterns result in reduced aerobic capacity, endurance, energy efficiency, and walking speed, negatively impacting the patient's functional abilities. There are different methodologies for the treatment gait impairments. Among them, treadmill training has been investigated as an effective therapeutic approach to post-stroke rehabilitation. Treadmill gait training may reduce asymmetry between hemibodies in hemiplegic patients. For this reason, our aim is to describe the effects of treadmill training on gait, focusing on its impact on thermal asymmetry, walking speed, aerobic endurance, and the biomechanical and kinematic characteristics of gait. Patients with hemiplegia will undergo treadmill-based gait training to evaluate its influence on the recovery of this sequel of stroke.
Eligibility Criteria
Inclusion Criteria: * Aged between 18 and 80 years * History of stroke at least six months prior * Presence of hemiplegia or hemiparesis * Ability to walk independently or with assistive devices Exclusion Criteria: * Cognitive impairments interfering with the understanding of treatment procedures * Inability to get on and maintain position on the treadmill * Severe heart failure * Active inflammatory or infectious conditions at the time of evaluation * Attendance below 80% of scheduled sessions
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07127861 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Gait. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07127861 currently recruiting?
Yes, NCT07127861 is actively recruiting participants. Contact the research team at martagomezmateos@usal.es for enrollment information.
Where is the NCT07127861 trial being conducted?
This trial is being conducted at Salamanca, Spain.
Who is sponsoring the NCT07127861 clinical trial?
NCT07127861 is sponsored by University of Salamanca. The trial plans to enroll 24 participants.